Join Now
Why Join?
Log In
Your Username/Email:
Your Password:
Remember Me
Forgot your password?
or
Home
Stocks
ETFs
Futures
Forex
Funds
Economy
Education
My Barchart
Market Pulse
Indices
Signals
Hot Stocks
Sectors
Portfolio Blogs
News & Commentary
Stock Screener
Enter ticker symbol
Extended Search
Symbol Search
Select a Commodity
--Grains and Oilseeds--
Wheat
Corn
Soybeans
Soybean Meal
Soybean Oil
Oats
Rough Rice
KCBT Wheat
Spring Wheat
Canola
--Currencies--
U.S. Dollar Index
British Pound
Canadian Dollar
Japanese Yen
Swiss Franc
Euro FX
Australian Dollar
Mexican Peso
--Energies--
Crude Oil
Heating Oil
Gasoline RBOB
Natural Gas
Ethanol
--Financials--
30 Year T-Bond
10 Year T-Note
5 Year T-Note
2 Year T-Note
10-Year Swaps
5-Year Swaps
30 Day Fed Funds
Eurodollar
--Indices--
S&P 500 Index
E-Mini S&P 500
Nasdaq 100
E-Mini Nasdaq
Dow Industrials
E-Mini Dow
NYSE Composite
S&P Midcap 400
E-Mini S&P Midcap
E-Mini Russell 2000
E-Mini SmallCap 600
CRB CCI Index
--Meats--
Live Cattle
Feeder Cattle
Lean Hogs
Pork Bellies
CME Milk
--Metals--
Gold
Silver
High Grade Copper
Platinum
Palladium
NYSE Gold
NYSE Silver
--Softs--
Cotton #2
Orange Juice
Coffee
Sugar #11
Cocoa
Sugar #16
Lumber
or enter GC* - Gold Futures
Quotes and Charts
Quote
Detailed Quote
Options Quotes
Technical Chart
Interactive Chart
Technical Analysis
Technical Analysis
Trader's Cheat Sheet™
Barchart Opinions
Barchart Opinion
Snapshot Opinion
Trading Strategies
Company Info
News Headlines
Profile
Key Statistics
Earnings
Analyst Ratings
Ratios
Income Statement
Balance Sheet
YOU ARE HERE:
Stocks
» Quotes and Charts » Quote
Symbols:
Top Stocks
Futures Markets
My Stocks
Save
Cancel
+ Portfolio
Celldex Therapeutics Inc (CLDX)
4.50
+0.02 (+0.45%)
7:36P EST
(NASDAQ)
-
Stock Price Quote as of
Friday, May 25th, 2012
High
4.53
Low
4.23
52Wk High
5.66
Since 02/03/12
(-20.49%)
52Wk Low
2.05
Since 10/04/11
(+119.51%)
Open
4.44
Prev Close
4.48
Volume
1,963,200
Avg Volume
1,819,910
EPS
-1.10
Div & Yield
N/A
P/E Ratio
0.00
Market Cap
$257.22 M
Weighted Alpha
+23.30
Standard Dev
+0.14
Sectors
Medical - Biomedical
,
All CLDX Sectors
View Detailed Quote
Chart Snapshot
Customize Chart
Barchart Opinion
View Opinion
Strong Buy
Buy
Hold
Sell
Strong Sell
Support & Resistance
Get Cheat Sheet
2nd Resistance Point
4.72
1st Resistance Point
4.61
Last Price
4.50
1st Support Level
4.31
2nd Support Level
4.12
Latest Headlines
More Headlines
BreakoutStocks.com Reports 3 Penny Stocks Leading in Volume in Thursday's Market - Celldex Therapeutics, Patriot Coal Corporation, Jetblue Airways Corp
PRWeb - Thu May 24, 7:02PM CDT
8-K: Celldex Therapeutics, Inc.
Edgar Online - Thu May 24, 8:06AM CDT
Celldex's CDX-011 Demonstrates High Response Rates in Patients with Metastatic Breast Cancer Expressing Elevated Levels of GPNMB and in Triple Negative Disease
BusinessWire - Wed May 23, 3:01PM CDT
Celldex Therapeutics to Host Call to Announce Topline Results from the EMERGE Study in Advanced Breast Cancer
BusinessWire - Fri May 18, 9:30AM CDT
Celldex Therapeutics Added to Nasdaq Biotechnology Index
BusinessWire - Tue May 15, 8:30AM CDT
Semi-Annual Changes to the NASDAQ Biotechnology Index
GlobeNewswire - Mon May 14, 6:02AM CDT
Celldex Therapeutics Inc posts higher net loss of USD13.5m for Q1 2012
M2 - Fri May 04, 7:07AM CDT
8-K: Celldex Therapeutics, Inc.
Edgar Online - Thu May 03, 2:34PM CDT
Celldex Reports First Quarter 2012 Financial Results
BusinessWire - Thu May 03, 7:30AM CDT
Celldex Announces Plans to Release Topline Results from the EMERGE Study in Advanced Breast Cancer
BusinessWire - Tue May 01, 6:00AM CDT